Country · Healthcare markets
Germany healthcare markets
178 reports across 5 categories, with market size and growth to 2033.
Germany healthcare markets178 reports across 5 categories, with market size and growth to 2033.
2023–2033 CAGR · estimates
Market size in 2023 · share of the world market
Active trials (recruiting, about to start or running)
Medtronic30 reports
Johnson & Johnson27 reports
Abbott Laboratories25 reports
Pfizer Inc.24 reports
GE Healthcare23 reports
Siemens Healthineers21 reports
Novartis AG19 reports
Philips Healthcare16 reports
Merck & Co., Inc.15 reports
Sanofi15 reports
Bayer AG15 reports
IBM Watson Health13 reports
Each market name opens its Germany report. To compare one market across every country, see market statistics.
| Market | 2023 | 2033 (projected) | CAGR | World share | Active trials |
|---|---|---|---|---|---|
| 3D Laparoscopy Imaging Systems | $117 Mn | $189 Mn | 4.9% | 3.7% | 1 |
| 3D Printed Implants | $132 Mn | $398 Mn | 11.7% | 3.7% | 2 |
| 3D Printing in Medical Application | $88 Mn | $480 Mn | 18.5% | 3.7% | 3 |
| Artificial Intelligence (AI) in Drugs Discovery | $22 Mn | $193 Mn | 24.3% | 3.7% | 23 |
| Artificial Intelligence (AI) in Healthcare | – | – | – | – | 89 |
| Artificial Intelligence (AI) in Life Sciences | $81 Mn | $744 Mn | 24.9% | 3.7% | 60 |
| Artificial Intelligence (AI) in Medical Imaging | $33 Mn | $270 Mn | 23.4% | 3.7% | 25 |
| Artificial Intelligence (AI) in Medicine | $304 Mn | $6.4 Bn | 35.7% | – | 89 |
| Artificial Intelligence (AI) in Pharma | – | – | – | – | 23 |
| Artificial Intelligence (AI) in Radiology | $22 Mn | $236 Mn | 26.8% | 3.7% | 6 |
| Artificial Intelligence (AI) in Remote Patient Monitoring | $33 Mn | $408 Mn | 28.6% | 3.7% | 4 |
| Artificial Intelligence (AI) Machine Learning(ML) in Healthcare | $70 Mn | $1.5 Bn | 36.2% | 3.7% | 89 |
| Blockchain in Genomics | $82 Mn | $1.8 Bn | 36.5% | 3.7% | 0 |
| Blockchain-as-a-Service | $77 Mn | $871 Mn | 27.5% | 3.7% | 0 |
| Brain Imaging, Biomarkers and NeuroInformatics | $25 Mn | $33 Mn | 2.9% | 3.7% | 186 |
| Brain PET-MRI Systems | $12 Mn | $20 Mn | 4.7% | 3.6% | 69 |
| Clinical Alarm Management | $64 Mn | $74 Mn | 1.5% | 3.7% | 5 |
| Clinical Data Management Systems | $92 Mn | $240 Mn | 10.1% | 3.7% | 9 |
| Connected Healthcare Market | $2.2 Bn | $20.5 Bn | 25.3% | 3.7% | 28 |
| Decentralized Clinical Trials(DCTs) | $60 Mn | $204 Mn | 13% | 3.7% | 141 |
| Dental 3D Printing | $124 Mn | $689 Mn | 18.7% | 3.7% | 0 |
| Dental CAD/CAM | $122 Mn | $267 Mn | 8.2% | 3.7% | 0 |
| Digital Biomarkers | $161 Mn | $2.9 Bn | 33.7% | 3.7% | 52 |
| Digital diabetes care | $470 Mn | $2.4 Bn | 17.5% | 3.7% | 17 |
| Digital Pathology Systems | $44 Mn | $135 Mn | 11.9% | 3.7% | 77 |
| Digital Therapeutics | $249 Mn | $1.4 Bn | 19.2% | 3.7% | 198 |
| Digital Twin | $62 Mn | $474 Mn | 22.5% | 3.7% | 4 |
| Digital X-ray | $637 Mn | $943 Mn | 4% | 3.7% | 165 |
| Electronic Health Record | $1.3 Bn | $1.7 Bn | 2.4% | 3.7% | 28 |
| Healthcare Information System | $10.6 Bn | $44.1 Bn | 15.3% | 3.7% | 335 |
| Healthcare IT | $17.7 Bn | $48.4 Bn | 10.6% | 3.7% | 58 |
| Home Healthcare | $13.3 Bn | $24 Bn | 6.1% | 3.7% | 171 |
| Internet Of Things In Healthcare | $3.6 Bn | $15 Bn | 15.2% | 3.7% | 1 |
| IoT in Healthcare | $6.6 Bn | $27.4 Bn | 15.3% | 3.7% | 1 |
| Long-term Care Software | $128 Mn | $357 Mn | 10.8% | 3.7% | 38 |
| Mental Health Apps | $205 Mn | $1.2 Bn | 18.9% | 3.7% | 20 |
| Pathology Imaging Systems | $59 Mn | $155 Mn | 10.1% | 3.7% | 77 |
| Point of Care Diagnostics | $1.7 Bn | $2.9 Bn | 5.6% | 3.7% | 587 |
| Remote Medication Management | $142 Mn | $585 Mn | 15.2% | 3.7% | 18 |
| Remote Patient Monitoring | $58 Mn | $255 Mn | 16% | 3.7% | 28 |
| Werable Healthcare Devices | $1.2 Bn | $6.3 Bn | 18% | 3.7% | 27 |
| Market | 2023 | 2033 (projected) | CAGR | World share | Active trials |
|---|---|---|---|---|---|
| Alopecia areata | – | – | – | – | 7 |
| Alzheimers Dignostic | $77 Mn | $126 Mn | 5.1% | 3.7% | 38 |
| Ambulance Service | $1.1 Bn | $1.9 Bn | 5.3% | 3.7% | 95 |
| Ambulatory Surgery Center | $1.5 Bn | $2.2 Bn | 4.3% | 3.7% | 724 |
| Antimicrobial Susceptibility Testing | – | – | – | – | 3 |
| Bioinformatics | $447 Mn | $1.5 Bn | 12.6% | 3.7% | – |
| Biomaterial Wound Dressing | $300 Mn | $484 Mn | 4.9% | 3.7% | 6 |
| Blood Gas and Electrolyte Analyzers | $103 Mn | $161 Mn | 4.6% | 3.7% | 30 |
| Bone Cancer Diagnostic | $40 Mn | $69 Mn | 5.6% | 3.7% | 85 |
| Brain Cancer Diagnostic | $55 Mn | $168 Mn | 11.8% | 3.7% | 87 |
| Breast Cancer Diagnostic | $150 Mn | $269 Mn | 6% | 3.7% | – |
| Clinical Laboratory Service | – | – | – | – | – |
| Dental Care Service | – | – | – | – | – |
| Dental Imaging | $124 Mn | $225 Mn | 6.1% | 3.7% | – |
| Dermatology Diagnostic | $952 Mn | $2.3 Bn | 9.4% | 3.7% | 276 |
| Fertility Service | $769 Mn | $1.2 Bn | 4.3% | 3.7% | – |
| Healthcare Electronic Data Interchange (EDI) | $146 Mn | $305 Mn | 7.6% | 3.7% | 8 |
| Healthcare In Vitro Diagnostic | $3.1 Bn | $3.7 Bn | 2% | 3.7% | 6 |
| Hospitals and Health Systems | $159.4 Bn | $231.5 Bn | 3.8% | 3.7% | 3,519 |
| Medical Billing | $165 Mn | $412 Mn | 9.6% | 3.7% | 8 |
| Medical Tourism | $2.7 Bn | $7.3 Bn | 10.4% | 3.7% | 0 |
| Nursing Education | $377 Mn | $695 Mn | 6.3% | 3.7% | 7 |
| Patient Support Programs (PSP) | $630 Mn | $2.3 Bn | 14% | 3.7% | 52 |
| Point Of Care (PoC) Molecular Diagnostic | $684 Mn | $1.4 Bn | 7.5% | 3.7% | 41 |
| Market | 2023 | 2033 (projected) | CAGR | World share | Active trials |
|---|---|---|---|---|---|
| Acute Care Needleless Connectors | $18 Mn | $31 Mn | 5.7% | 3.7% | – |
| Advanced Bipolar Direct Energy Devices | $114 Mn | $221 Mn | 6.9% | 3.7% | – |
| Aesthetic Lasers and Energy Devices | $59 Mn | $158 Mn | 10.3% | 3.7% | – |
| Air Ambulance Life Support Solutions | $164 Mn | $331 Mn | 7.3% | 3.7% | – |
| Airway Management Devices | $73 Mn | $102 Mn | 3.4% | 3.7% | – |
| Anastomosis Devices | $115 Mn | $188 Mn | 5% | 3.7% | – |
| Anesthesia & Respiratory Devices | $1.1 Bn | $2.2 Bn | 7.7% | 3.7% | – |
| Anesthesia Monitoring Devices | $97 Mn | $267 Mn | 10.7% | 3.7% | – |
| Angiography Devices | $456 Mn | $708 Mn | 4.5% | 3.7% | – |
| Angioplasty Balloons | $149 Mn | $181 Mn | 2% | 3.7% | – |
| Anti-Snoring Devices | $46 Mn | $90 Mn | 7% | 3.7% | – |
| Apheresis Equipments | $93 Mn | $143 Mn | 4.4% | 3.7% | – |
| Arrhythmia Monitoring Devices | $220 Mn | $316 Mn | 3.7% | 3.7% | – |
| Assisted Walking Aids | $84 Mn | $121 Mn | 3.7% | 3.7% | – |
| Audiology Devices | $287 Mn | $449 Mn | 4.6% | 3.7% | – |
| Defibrillator | $649 Mn | $970 Mn | 4.1% | 3.7% | – |
| Dental Articulators | $14 Mn | $22 Mn | 4.6% | 3.7% | – |
| Dental Caries Detectors | $14 Mn | $35 Mn | 10% | 3.6% | – |
| Dental Diagnostic and Surgical Equipments | $439 Mn | $735 Mn | 5.3% | 3.7% | – |
| Dental X-Ray Equipments | $64 Mn | $108 Mn | 5.4% | 3.7% | – |
| Diabetes Care Devices | $1.6 Bn | $2.3 Bn | 4.1% | 3.7% | – |
| Digital Diabetes Management | – | – | – | – | – |
| Direct Energy Medical Devices | $404 Mn | $554 Mn | 3.2% | 3.7% | – |
| Disposable Surgical Devices | $331 Mn | $565 Mn | 5.5% | 3.7% | – |
| Insulin Delivery Devices | $582 Mn | $921 Mn | 4.7% | 3.7% | – |
| Insulin Patch Pumps | $33 Mn | $86 Mn | 10.2% | 3.7% | – |
| Rehabilitation Equipments | $732 Mn | $1.1 Bn | 4.3% | 3.7% | – |
| Market | 2023 | 2033 (projected) | CAGR | World share | Active trials |
|---|---|---|---|---|---|
| Adaptogens | $297 Mn | $567 Mn | 6.7% | 3.7% | – |
| Amino Acid | – | – | – | – | – |
| Anthelmintic Drug | – | – | – | – | – |
| Antioxidants | – | – | – | – | – |
| Antipyretics OTC | – | – | – | – | – |
| BCAA Supplement | $51 Mn | $83 Mn | 4.9% | 3.7% | – |
| Beauty Supplements | $150 Mn | $306 Mn | 7.4% | 3.7% | – |
| Biotin Supplement | $15 Mn | $20 Mn | 3.2% | 3.7% | – |
| Bone & Joint Health Supplements | $439 Mn | $689 Mn | 4.6% | 3.7% | – |
| Calcium Supplements | $92 Mn | $138 Mn | 4.2% | 3.7% | – |
| Cannabidiol (CBD) Supplements | $194 Mn | $785 Mn | 15% | 3.7% | – |
| Cardiovascular Health Supplements | $249 Mn | $365 Mn | 3.9% | 3.7% | – |
| Clinical Nutrition | $1 Bn | $1.7 Bn | 5.3% | 3.7% | – |
| Coenzyme Q10 | $18 Mn | $37 Mn | 7.2% | 3.7% | – |
| Collagen Supplements | $81 Mn | $123 Mn | 4.3% | 3.7% | – |
| Creatine | $22 Mn | $34 Mn | 4.5% | 3.7% | – |
| Dietary Supplements | $11.3 Bn | $17.3 Bn | 4.4% | 3.7% | – |
| Eye Health Supplements | $114 Mn | $175 Mn | 4.4% | 3.7% | – |
| Functional Food | $10.4 Bn | $16.8 Bn | 4.9% | 3.7% | – |
| Hair Growth Supplements | $66 Mn | $113 Mn | 5.5% | 3.7% | – |
| Herbal Supplements | $3 Bn | $5.3 Bn | 5.8% | 3.7% | – |
| Immune Health Supplement | – | – | – | – | – |
| Iron Supplement | $73 Mn | $116 Mn | 4.7% | 3.7% | – |
| Men's Health Supplements | $663 Mn | $1.1 Bn | 5% | 3.7% | – |
| Mood and Stress Supplements | $384 Mn | $708 Mn | 6.3% | 3.7% | – |
| Nutritional Supplements | $14.1 Bn | $23 Bn | 5% | 3.7% | – |
| Omega 3 Fatty Acid | $150 Mn | $259 Mn | 5.6% | 3.7% | – |
| Oncology Nutrition | $77 Mn | $131 Mn | 5.5% | 3.7% | – |
| Osteoporosis Supplements | $114 Mn | $180 Mn | 4.7% | 3.7% | – |
| Over The Counter (OTC) Analgesics | $805 Mn | $944 Mn | 1.6% | 3.7% | – |
| Over The Counter (OTC) Antifungal | $92 Mn | $112 Mn | 2% | 3.7% | – |
| Over The Counter (OTC) Consumer | $5.5 Bn | $7.7 Bn | 3.4% | 3.7% | – |
| Over The Counter (OTC) Drugs | $6.5 Bn | $8.7 Bn | 2.9% | 3.7% | – |
| Over The Counter (OTC) Gastrointestinal Drugs | $205 Mn | $252 Mn | 2.1% | 3.7% | – |
| Over The Counter (OTC) Medications for Cough, Cold & Flu Drugs | $531 Mn | $666 Mn | 2.3% | 3.7% | – |
| Over The Counter (OTC) Ophthalmic Drugs | $132 Mn | $172 Mn | 2.7% | 3.7% | – |
| Over The Counter (OTC) Pharmaceuticals | $6.5 Bn | $8.7 Bn | 2.9% | 3.7% | – |
| Over The Counter (OTC) Sleep Aid Products | $194 Mn | $241 Mn | 2.2% | 3.7% | – |
| Over The Counter (OTC) Vitamins and Minerals | $1.2 Bn | $1.7 Bn | 3.7% | 3.7% | – |
| Plant-Based Supplements | $450 Mn | $822 Mn | 6.2% | 3.7% | – |
| Prebiotics | $297 Mn | $769 Mn | 10% | 3.7% | – |
| Probiotic Supplements for Gut Health | $223 Mn | $378 Mn | 5.4% | 3.7% | – |
| Protein Supplement | $732 Mn | $1.3 Bn | 5.6% | 3.7% | – |
| Sports Nutrition | $1.9 Bn | $3.4 Bn | 6.1% | 3.7% | – |
| Vitamin B12(Cobalamin) | $11 Mn | $16 Mn | 3.7% | 3.7% | – |
| Vitamin D Supplements | – | – | – | – | – |
| Weight Management Supplement | – | – | – | – | – |
| Women's Health Supplements | $732 Mn | $1.2 Bn | 5% | 3.7% | – |
| Market | 2023 | 2033 (projected) | CAGR | World share | Active trials |
|---|---|---|---|---|---|
| Abuse Deterrent Opioids | – | – | – | – | – |
| Alexipharmic Drugs | – | – | – | – | – |
| Alopecia Drugs (Hair Loss) | – | – | – | – | – |
| Alzheimer Drugs | $183 Mn | $299 Mn | 5% | – | – |
| Aminoglycosides | – | – | – | – | – |
| Anemia Drugs | – | – | – | – | – |
| Anti-Aging | $3.2 Bn | $5.9 Bn | 6.3% | 3.7% | – |
| Anti-Depressants Drugs | $659 Mn | $721 Mn | 0.9% | 3.7% | – |
| Anti-Nerve Growth Factor | – | – | – | – | – |
| Anti-Venom | – | – | – | – | – |
| Anticoagulants | – | – | – | – | – |
| Antithrombotic Drugs | – | – | – | – | – |
| Artificial Skin | $92 Mn | $135 Mn | 4% | 3.7% | – |
| Asthma & COPD Drugs | $1.8 Bn | $2.3 Bn | 2.2% | 3.7% | – |
| Atherosclerosis Drugs | – | – | – | – | – |
| Atopic Dermatitis Drugs | $411 Mn | $1.1 Bn | 10.4% | 3.7% | – |
| Autologous Matrix-induced Chondrogenesis | – | – | – | – | – |
| Axial Spondyloarthritis (axSpA) | – | – | – | – | – |
| Biological Safety Testing | – | – | – | – | – |
| Biosimilar Monoclonal Antibodies | – | – | – | – | – |
| Biosimilars | $1.4 Bn | $10.8 Bn | 23.1% | 3.7% | – |
| Blood Plasma | – | – | – | – | – |
| Bone Marrow Aspirate Concentrates | – | – | – | – | – |
| Burn Care | – | – | – | – | – |
| Burn Ointment | – | – | – | – | – |
| Cancer Supportive Care Drugs | $908 Mn | $1.2 Bn | 2.9% | 3.7% | – |
| Cannabidiol (CBD) | $807 Mn | $3.3 Bn | 15% | 3.7% | – |
| Cannabis | $1.2 Bn | $3.8 Bn | 11.7% | 3.7% | – |
| Cell Based Immunotherapy | $608 Mn | $4.2 Bn | 21.2% | 3.7% | – |
| Contraceptives Drugs | $922 Mn | $1.5 Bn | 5% | 3.7% | – |
| Cord Blood Banking Service | $70 Mn | $110 Mn | 4.7% | 3.7% | – |
| Diabetes Management | $2.9 Bn | $4.8 Bn | 5.3% | 3.7% | – |
| Diabetic Retinopathy Drugs | $395 Mn | $597 Mn | 4.2% | 3.7% | – |
| Epilepsy Drugs | $351 Mn | $416 Mn | 1.7% | 3.7% | – |
| Gastroesophageal Reflux Disease (GERD) Drugs | $190 Mn | $196 Mn | 0.3% | 3.7% | – |
| Gastrointestinal Drugs | $2 Bn | $2.6 Bn | 2.8% | 3.7% | – |
| HIV Drugs | $1.1 Bn | $1.6 Bn | 4% | 3.7% | – |
| Oncology/Cancer Drugs | $6.5 Bn | $12.3 Bn | 6.6% | 3.7% | – |
"–" means we have no size for that market here yet. Values for 2033 are projected from the 2023 size and the CAGR.
Sources: market sizes and growth: Acuitas Health Analytics research. Trials: ClinicalTrials.gov (fetched 10 Nov 2026); found by search words, so counts are a guide, and one trial can count in more than one market. Health figures: WHO Global Health Observatory. People and health spending: World Bank. Public figures fetched 10 Nov 2026.